|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/495 | |
| A61P 29/02 |
| (11) | Patento numeris | 1736158 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06017231.9 |
| Europos patento paraiškos padavimo data | 2000-05-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-12-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2009-08-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 99109295 | 1999-05-27 | EP |
| (72) |
Bartoszyk, Gerd, DE
Seyfried, Christoph, DE
van Amsterdam, Christoph, DE
Boettcher, Henning, DE
Sedman, Ewen, GB
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts |
| Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts |